Fig. 1From: When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case reportMagnetic resonance imaging shows the exemplary course of pancreatic metastases from renal cell cancer. The magnetic resonance imaging at the left side was performed directly before the treatment with a tyrosine kinase inhibitor was stopped in July 2016 (a), the MRI at the right side 13 months later in August 2017 (b).Back to article page